ucsf logo

Artificial kidney project led by Shuvo Roy chosen for accelerated FDA program

Speaking on a White House panel discussing President Obama's just-released Bioeconomy Blueprint, UCSF Vice Chancellor for Research Keith Yamamoto, PhD, cited the implantable bioartificial kidney project led by UCSF bioengineer Shuvo Roy, PhD, as a prime example of biomedical collaboration with potentially major social and economic impact. MoreArtificial kidney project led by Shuvo Roy chosen for accelerated FDA program

Tags: 
Food and Drug Administration
FDA
National Bioeconomy Blueprint
The White House
The Kidney Project
end stage renal disease
kidney failure
dialysis
kidney transplant
filtration
blood
bioreactor
silicon
implant
artificial kidney
nanotechnology
membrane
Innovation Pathway 2.0
Key people: 
Shuvo Roy
Keith Yamamoto

Next topic: About QBC